> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-210/
- Published: 2019-02-10T12:00:00.000Z
- Updated: 2026-09-15T01:02:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143350

[**FDA Seeks Industry Reps to Serve on Advisory Committees**](https://www.fdaweb.com/fda-seeks-industry-reps-to-serve-on-advisory-committees/)  
*Federal Register* notice: FDA requests nominations for nonvoting industry representatives to serve on its public advisory committees for CDER. 02/08/2019

[**Info Collection Extension for Generic Drug Fee Coversheet**](https://www.fdaweb.com/info-collection-extension-for-generic-drug-fee-coversheet/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for its “Generic Drug User Fee Coversheet.” 02/08/2019

[**Pilot Program on Drug Supply Chain**](https://www.fdaweb.com/pilot-program-on-drug-supply-chain-2/)  
*Federal Register* notice: FDA announces the start of a pilot program under the Drug Supply Chain Security Act. 02/08/2019

[**Public Warnings on Recalls Guidance**](https://www.fdaweb.com/public-warnings-on-recalls-guidance/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Public Warning and Notification of Recalls.” 02/08/2019

[**Guide on Depot Buprenorphine Product Development**](https://www.fdaweb.com/guide-on-depot-buprenorphine-product-development-2/)  
*Federal Register* notice: FDA posts a final guidance entitled “Opioid Use Disorder: Developing Depot Buprenorphine Products for Treatment.” 02/08/2019

[**Pilot Program on Drug Supply Chain**](https://www.fdaweb.com/pilot-program-on-drug-supply-chain/)  
*Federal Register* notice: FDA announces the start of a pilot program under the Drug Supply Chain Security Act. 02/08/2019

[**Panel to Review Karyopharm Multiple Myeloma Drug**](https://www.fdaweb.com/panel-to-review-karyopharm-multiple-myeloma-drug/)  
*Federal Register* notice: FDA announces a 2/26 Oncologic Drugs Advisory Committee meeting to review a Karyopharm Therapeutics NDA for treating multiple myeloma. 02/07/2019

[**Eosinophilic Esophagitis Drug Development Guide**](https://www.fdaweb.com/eosinophilic-esophagitis-drug-development-guide/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Eosinophilic Esophagitis: Developing Drugs for Treatment.” 02/07/2019

[**Guide on Combo Product Pathways**](https://www.fdaweb.com/guide-on-combo-product-pathways/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Principles of Premarket Pathways for Combination Products” that discusses how to determine which type of premarket submission is appropriate. 02/07/2019